Table 2.

Associations between Wnt2, GSK3β, β-catenin and the clinicopathological characteristic in ESCC

	Kazakh			Han			Total
	Wnt2	GSK3β	β-catenin	Wnt2	GSK3β	β-catenin	Wnt2	GSK3β	β-catenin
Positive rate	60.0%	8.9%	54.8%	52.0%	6.2%	60%	56.3%	7.2%	55.5%
P (Tumor location)	0.270	0.109	0.568	0.681	0.087	0.701	0.605	0.002	0.314
P (Tumor size)	0.176	0.348	0.116	0.954	0.632	0.738	0.773	0.294	0.075
P (Degree of differentiation)	0.031	0.394	0.636	0.854	0.666	0.72	0.060	0.707	0.584
P (AJCC stage)	0.542	0.815	0.057	0.165	0.789	0.260	0.974	0.543	0.091
P (Lymph node metastasis)	0.214	0.666	0.134	0.590	0.571	0.212	0.234	0.858	0.117
P (nation)							0.659	0.625	0.401